Huadong Medicine Co., Ltd (SHE:000963)
33.75
-0.46 (-1.34%)
Apr 28, 2026, 3:04 PM CST
Huadong Medicine Market Cap
Huadong Medicine has a market cap or net worth of 60 billion as of April 28, 2026. Its market cap has decreased by -7.09% in one year.
Market Cap
60.00B
Enterprise Value
58.78B
Revenue
44.06B
Ranking
n/a
PE Ratio
17.13
Stock Price
33.75
Market Cap Chart
Since January 2, 2001, Huadong Medicine's market cap has increased from 4.21B to 60.00B, an increase of 1,324.93%. That is a compound annual growth rate of 11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 60.00B | -13.09% |
| Dec 31, 2025 | 69.03B | 14.00% |
| Dec 31, 2024 | 60.55B | -16.55% |
| Dec 29, 2023 | 72.56B | -11.60% |
| Dec 30, 2022 | 82.09B | 16.70% |
| Dec 31, 2021 | 70.34B | 51.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Biokin Pharmaceutical | 117.27B |
| Zhejiang NHU Company | 106.85B |
| Yunnan Baiyao Group Co.,Ltd | 97.12B |
| Shanghai Fosun Pharmaceutical (Group) | 62.77B |
| Shenzhen Salubris Pharmaceuticals | 61.89B |
| China Resources Sanjiu Medical & Pharmaceutical | 45.18B |
| Beijing Tongrentang | 37.88B |
| Changchun High-Tech Industry (Group) | 34.30B |